Meagan Parrish
Lead Editor | @meaganparrishMeagan Parrish is the lead editor for PharmaVoice. She got her professional start as an editor at a women’s magazine in her current home of Madison, Wisconsin, before jumping into B2B industry reporting. She spent three years covering the chemicals, energy, food and healthcare sectors at numerous publications, and then became a full-time pharma journalist. During her four years as senior editor at Pharma Manufacturing, Meagan was a three-time Neal Awards finalist, and was honored to receive numerous other accolades for her industry reporting. Her highest honor was the Stephen Barr Award, a prestigious “best in show” award chosen from the 2020 pool of Gold-winning articles by the American Society of Business Publication Editors (ASBPE) for her coverage of contaminated APIs in drugs imported from overseas. Pharma Manufacturing also snagged the 2021 Magazine of the Year award from ASBPE. Meagan joined PharmaVoice in late 2021 after the publication was acquired by Industry Dive and relaunched as a daily digital. But Meagan’s most important job is being Mom to her two daughters and teaching them to cook, dance and talk in funny accents.
69 articles by Meagan Parrish
-
Viral roots: A look at how modern outbreaks began
March 22, 2023 -
The PharmaVoice 100 — Who makes the cut
March 15, 2023 -
Multimillion-dollar therapies are changing how payers foot the bill
Feb. 28, 2023 -
Managing for resilience: Passage’s ups and downs in gene therapy
Feb. 15, 2023 -
The unique playbook of Biohaven’s CEO
Feb. 8, 2023 -
Gilead’s commercial chief on why 2023 will be a ‘coming out’ year
Jan. 26, 2023 -
After ‘limping along,’ Novavax sees a path forward
Jan. 18, 2023 -
How biotechs can weather the market storm
Jan. 13, 2023 -
A new mission in menopause — extending the lives of women
Jan. 5, 2023 -
A historic approval could transform CSL from being ‘the biggest company no one has ever heard of’
Dec. 6, 2022 -
10 of our most popular articles in 2022
Nov. 30, 2022 -
5 enduring mysteries of the Barry and Honey Sherman murders
Nov. 28, 2022 -
#HLTH: ‘Unicorns are real’ — and here’s how they can navigate a challenging biotech market
Nov. 15, 2022 -
Acumen cruises into the fast lane with novel Alzheimer’s treatment
Nov. 3, 2022 -
Backed by celebrity interest, Novo is finding new success in weight loss — while staying true to its roots
Oct. 25, 2022 -
5 impactful drug trial failures from the last year
Oct. 19, 2022 -
The Novartis U.S. Foundation’s president on the ‘magical piece’ of its 10-year health equity plan
Oct. 17, 2022 -
Where the CEO of ADC Therapeutics sees ‘huge potential’ in the tech beyond oncology
Oct. 12, 2022 -
The 2 areas in life sciences most in need of talent
Oct. 4, 2022 -
Compass has the most advanced psychedelic drug in trials — but it needs a new approach to rollout to make it a success
Sept. 27, 2022 -
Disrupters: Abigail Jenkins
Sept. 6, 2022 -
Tech Wizards: Baba Shetty
Sept. 6, 2022 -
Innovators: Dr. Barbara Klencke
Sept. 6, 2022 -
Entrepreneurs: Ben Yerxa
Sept. 6, 2022 -
Entrepreneurs: Dr. Bobak Azamian
Sept. 6, 2022